Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Tivic Health Awarded the Gold Electrode Award from Neurotech Leaders Forum

Tivic Health Systems Inc.
Posted on: 29 Oct 18

According to Scientific American, electroceuticals, a branch of neurotechnology, is one of the top 10 emerging technologies of 2018. One of the prominent neurotechnology organizations, Neurotech Reports, held their annual Neurotech Leaders Forum recently in San Francisco, California. During the event, Tivic Health Systems was awarded the Gold Electrode Award for Most Promising Start-up. Blake Gurfein, PhD, Tivic Health’s VP of Research and Scientific Affairs and Assistant Professor at UC San Francisco, presented a talk and accepted the award.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181029005064/en/

Blake Gurfein, PhD and Tivic Health's VP of Research & Scientific Affairs receiving Gold Electrode Award from Jim Cavuoto, Editor and Publisher of Neurotech Reports at the recent Neurotech Leaders Forum (Photo: Business Wire)

James Cavuoto, editor and publisher of The Neurotech Business Report says, “Our editors were impressed by Tivic Health’s innovative technology to address an unmet medical need. The scientific and management team seem well positioned to bring the ClearUP Sinus Pain Relief device to market.” Gurfein adds, “I was attracted to join Tivic Health because they are lean, execution-oriented and serious about evidence-based products that are efficacious and address real clinical needs. Because of my previous research in neuromodulation, I saw the potential promise of the ClearUP Sinus Pain Relief device. In less than a year, we have progressed from a well-designed prototype to FDA clearance-pending.”

The Neurotech Leaders Forum is a two-day conference for neurotechnology executives and entrepreneurs to interact with investors, partners and technologists. This year it attracted 120 international and US neurotechnology professionals.

Tivic Health is actively engaging with investor communities in preparation for the ClearUP™ Sinus Pain Relief launch.

FDA 510 K clearance is pending. ClearUP™ Sinus Pain Relief is an investigational technology. Claims have not been evaluated by the FDA. This device is not currently for sale in the U.S.

About Tivic Health Systems Inc.

Tivic Health Systems Inc. (Tivic Health™) is a bioelectronic device company dedicated to developing microcurrent therapy solutions for chronic diseases and conditions. Tivic Health’s first product, ClearUP™ Sinus Pain Relief, targets sinus pain associated with chronic sinusitis, allergic rhinitis and other common sources of sinus pain.

Tivic Health, founded in 2016, is part of a $6.2B global neuromodulation industry. The team is dedicated to harnessing the power of neuromodulation for home use products, empowering people to improve their health and quality of life.

For more information, visit www.tivichealth.com and follow us on www.twitter.com/TivicHealth and www.facebook.com/TivicHealth.

Forward Looking Statement

This news release contains forward-looking statements that are based on the current expectations and beliefs of Tivic Health Systems Inc. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including FDA clearance, product launch and timing.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181029005064/en/

Business Wire
www.businesswire.com

Last updated on: 29/10/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.